Carlsmed Inc. has appointed Jennifer Kamocsay as chief legal officer and secretary. She will serve as legal counsel for the company and oversee compliance and corporate governance.

Kamocsay has more than two decades of corporate legal experience as in-house counsel across life science and technology sectors at Akoya Biosicences, Rubius Therapeutics Inc., and Progress Software Corporation.

“We are pleased to welcome Jennifer to the Carlsmed leadership team as we strengthen our organization and strategically expand our leadership team following our IPO,” Carlsmed Chairman/CEO Mike Cordonnier stated. “Her deep expertise in corporate governance, securities law and broader legal strategy will be instrumental as we continue to scale our business and prepare for our cervical commercial launch.”

Before her tenure at Akoya, Kamocsay was general counsel and corporate secretary of Rubius Therapeutics Inc., where she was responsible for overseeing and managing all legal affairs. Before Rubius, she served as associate general counsel and assistant secretary at Progress Software Corporation, where she managed the company’s corporate, securities law, and M&A initiatives. Kamocsay began her career at Skadden, Arps, Slate, Meagher & Flom LLP, where she provided counsel to public and private company clients in the biotechnology and pharmaceutical industries on M&A, securities law, and corporate governance matters.

Kamocsay earned a bachelor of arts degree in history from the University of California – Los Angeles and a J.D. from Northeastern University School of Law.

Carlsmed is a medical technology company pioneering artificial intelligence-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease healthcare costs.